Sitting on a Pile of Cash, AQST is a Speculative Buy with a Long Term Very Bullish Bias

$AQST Friday, Aquestive Therapeutics Inc. (NASDAQ:AQST) was reiterated a Buy and its price target was raised to 15 Vs 5.75 close at HC Wainwright, as a royalty program it is involved in with Sunovion Pharmaceuticals, a Private company, received FDA approval. The consensus target is 17.17 Vs a 52 wk trading range of 1.41 -10. […]